Reduction of Respiratory Syncytial Virus Titer in the Lungs of Mice after Intranasal Immunization with a Chimeric Peptide Consisting of a Single CTL Epitope Linked to a Fusion Peptide
- 1 January 1998
- Vol. 240 (2) , 376-381
- https://doi.org/10.1006/viro.1997.8923
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Structural Properties of Chimeric Peptides Containing a T‐cell Epitope Linked to a Fusion Peptide and their Importance for in Vivo Induction of Cytotoxic T‐cell ResponsesEuropean Journal of Biochemistry, 1997
- Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infectionJournal of General Virology, 1996
- Pathogenesis of Respiratory Syncytial Virus Vaccine-augmented PathologyAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Vaccines and cytokine-mediated pathology in RSV infectionTrends in Microbiology, 1994
- From the National Institute of Allergy and Infectious Diseases and the World Health Organization: Respiratory Syncytial and Parainfluenza VirusesThe Journal of Infectious Diseases, 1990
- Primary respiratory syncytial virus infection in miceJournal of Medical Virology, 1988
- Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.The Journal of Experimental Medicine, 1988
- Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virusVirology, 1974
- FIELD EVALUATION OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE AND A TRIVALENT PARAINFLUENZA VIRUS VACCINE IN A PEDIATRIC POPULATION1American Journal of Epidemiology, 1969
- RESPIRATORY VIRUS IMMUNIZATIONAmerican Journal of Epidemiology, 1969